Literature DB >> 16209065

Transforming Growth Factor Beta and breast cancer.

Virginia Kaklamani1, Boris Pasche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16209065     DOI： 10.1007/0-387-24361-5_6

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  5 in total

1.  Secretory products of breast cancer cells upregulate hyaluronan production in a human osteoblast cell line.

Authors:  Nandita Bose; Anna M Masellis
Journal:  Clin Exp Metastasis       Date:  2006-04-27       Impact factor: 5.150

2.  Debate about TGFBR1 and the susceptibility to colorectal cancer.

Authors:  Laura Valle
Journal:  World J Gastrointest Oncol       Date:  2012-01-15

Review 3.  Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies.

Authors:  Reham Ajina; David J Zahavi; Yong-Wei Zhang; Louis M Weiner
Journal:  Semin Cancer Biol       Date:  2019-12-19       Impact factor: 15.707

4.  TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.

Authors:  J Skoglund Lundin; J Vandrovcova; B Song; X Zhou; M Zelada-Hedman; B Werelius; R S Houlston; A Lindblom
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

5.  TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.

Authors:  B Song; S Margolin; J Skoglund; X Zhou; J Rantala; S Picelli; B Werelius; A Lindblom
Journal:  Br J Cancer       Date:  2007-09-11       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.